Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
Once fears of the delta variant subside and the recovery continues, we believe that small caps may continue as important pieces of the economic recovery. Until then, Brian Manby explains why investors should be wary of prevailing large-cap valuations in their portfolios.
Mapping the road ahead for any market environment is already hard enough, but it’s even more difficult this time as we finally exit the pandemic. No matter your economic forecast for the near future, Brian Manby explains why the WisdomTree U.S. SmallCap Fund (EES) can be a part of it.
When investors think of foreign small-cap equities, they often intuitively expect discounted valuations relative to U.S. large caps, to compensate for higher volatility. Jeremy Schwartz and Matt Wagner explain why Japanese small caps may deserve consideration by value-starved asset allocators.
The bond sell-off earlier this year has led to high levels of interest rate sensitivity in the stock market. Jeff Weniger makes the case for equity investors to allocate toward value stocks in a rising interest rate environment.